Tip - Premier Research's New Survey of Rare Diseases, Orphan Drugs Highlights Regulatory Challenges - Premier Research

A new survey of clinical trial decision makers commissioned by Premier Research reports that nearly two-thirds (64%) of respondents said that among the most difficult factors in recruiting for a rare disease or orphan drug clinical trial was not only finding patients to join and remain in trials, but identifying and setting up investigative sites for studies.